References
- Krog GR, Donneborg ML, Hansen BM, et al. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer. Pediatr Res 2021;90:74–81. doi: 10.1038/s41390-020-01232-5
- Pegoraro V, Urbinati D, Visser GHA, et al. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children. PLoS One 2020;15:7. doi: 10.1371/journal.pone.0235807
- Klein HG, Anstee DJ. Mollison’s blood transfusion in clinical medicine. 11th ed. Hoboken, NJ: Wiley-Blackwell Publishing, 2005.
- Bennardello F, Coluzzi S, Curciarello G, et al. Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) and Italian Society of Gynaecology and Obstetrics (SIGO) working group: recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn. Blood Transfus 2015;13:109–34. doi: 10.2450/2014.0119-14
- Harmening DM. Modern blood banking and transfusion practices. 5th ed. Philadelphia, PA: F.A. Davis Company, 2005: 392.
- Bel Hadj I, Boukhris R, Khalsi F, et al. ABO hemolytic disease of newborn: does newborn’s blood group a risk factor? Tunis Med 2019;97:455–60.
- Adewuyi JO, Gwanzura C. Racial difference between White and Black Zimbabweans in the haemolytic activity of A, B, O antibodies. Afr J Med Med Sci 2001;30:71–4.
- Mourant AE, Kopéc AC, Domaniewska-Sobczak K. The distribution of the human blood groups and other biochemical polymorphisms. 2nd ed. Oxford: Oxford University Press, 1976.
- Badet J, Ropars C, Cartron JP, et al. Groups of alpha-D-galactosyltransferase activity in sera of individuals with normal B phenotype. II. Relationship between transferase activity and red cell agglutinability. Vox Sang 1976;30:105. doi: 10.1111/j.1423-0410.1976.tb02800.x
- Zonneveld R, van der Meer-Kapelle L, Sylva M, et al. Severe fetal hemolysis and cholestasis due to high-titer maternal IgG anti-A antibodies. Pediatrics 2019;143:e20182859. doi: 10.1542/peds.2018-2859
- Grundbacher FJ. Genetics of anti-A and anti-B levels. Transfusion 1976;16:48–55. doi: 10.1046/j.1537-2995.1976. 16176130837.x
- Redman M, Malde R, Contreras M, et al. Comparison of IgM and IgG anti-A and anti-B levels in Asian, Caucasian and Negro donors in the north-west Thames region. Vox Sang 1990;59:89–91. doi: 10.1111/j.1423-0410.1990.tb05016.x
- American Academy of Pediatrics Subcommittee on Hyper-bilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316. doi: 10.1542/peds.114.1.297
- Rahmati A, Farhat AS, Boroumand-Noughabi S, Soleymani F, Keramati M. Retrospective analysis of direct antiglobulin test positivity at tertiary academic hospital over 10 years. Transfus Apher Sci 2022;61:103358. doi: 10.1016/j.transci.2022.103358
- Matteocci A, De Rosa A, Buffone E, et al. Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years. Transfus Med 2019;29:197–201. doi: 10.1111/tme.12512
- Panda B. The incidence of the ABO hemolytic disease of the newborn and significance of various serological and laboratory investigations in its evaluation and diagnosis. Vox Sang 2021;116(S1):25–6.
- Siyah Bilgin B, Altun Koroglu O, Yalaz M, Karaman S, Kultursay N. Factors affecting bilirubin levels during first 48 hours of life in healthy infants. Biomed Res Int 2013;2013:316430. doi: 10.1155/2013/316430
- El-Kabbany ZA, Toaima NN, Toaima TN, Gamal El-Din MY. Does anaesthesia in mothers during delivery affect bilirubin levels in their neonates? Korean J Pediatr 2017;60:385–9. doi: 10.3345/kjp.2017.60.12.385
- Akgül S, Korkmaz A, Yigit S, Yurdakök M. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter? Turk J Pediatr 2013;55:506–9
- Bhat YR, Kumar CG. Morbidity of ABO haemolytic disease in the newborn. Paediatr Int Child Health 2012;32:93–6. doi: 10.1179/2046905512Y.0000000002
- Bujandric N, Grujic J. Exchange transfusion for severe neonatal hyperbilirubinemia: 17 years’ experience from Vojvodina, Serbia. Indian J Hematol Blood Transfus 2016;32:208–14. doi: 10.1007/s12288-015-0534-1
- Strauss RG. Hemolytic disease of the fetus/newborn: reflections on articles from Transfusion Volume 1. Transfusion 2010;50:748–51. doi: 10.1111/j.1537-2995.2009.02453.x
- Basu S, Kaur R, Kaur G. Hemolytic disease of the fetus and newborn: current trends and perspectives. Asian J Transfus Sci 2011;5:3–7. doi: 10.4103/0973-6247.75963
- Kemper AR, Newman TB, Slaughter JL, et al. Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2022;150:e2022058859.